{"schemaVersion":"peptidescanner-evidence-bundle/v1","canonicalUrl":"https://peptidescanner.com/evidence/v1/peptides/tesofensine.json","manifestUrl":"https://peptidescanner.com/evidence/v1/manifest.json","peptide":{"slug":"tesofensine","name":"Tesofensine","url":"https://peptidescanner.com/peptides/tesofensine/"},"addressing":"objects is keyed by objectPathId. A URL fragment #<objectPathId> on this file names one evidence object. Every version of a record is placed in the bundle of the record's current first peptide.","objectCount":11,"objects":{"clinicaltrials-gov-nct00006077-tesofensine-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00006077-tesofensine:v1","objectPathId":"clinicaltrials-gov-nct00006077-tesofensine-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00006077-tesofensine/","json":"https://peptidescanner.com/evidence/v1/peptides/tesofensine.json#clinicaltrials-gov-nct00006077-tesofensine-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/tesofensine.md#clinicaltrials-gov-nct00006077-tesofensine-v1"},"story":{"slug":"clinicaltrials-gov-nct00006077-tesofensine","version":1,"domain":"Clinical trials","dateInSource":"2008-03-04","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["tesofensine"],"peptides":[{"slug":"tesofensine","url":"https://peptidescanner.com/peptides/tesofensine/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00006077","sourceIds":["ctg-observation-nct00006077-2008-03-04-bfc2ad48e44c"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00006077 at 2026-11-16T17:29:46.323Z. Its registry update date was 2008-03-04, and PeptideScanner's reviewed identity mapping was tesofensine.","sourceIds":["ctg-observation-nct00006077-2008-03-04-bfc2ad48e44c"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00006077 at 2026-11-16T17:29:46.323Z. Its registry update date was 2008-03-04, and PeptideScanner's reviewed identity mapping was tesofensine.","sourceIds":["ctg-observation-nct00006077-2008-03-04-bfc2ad48e44c"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00006077-2008-03-04-bfc2ad48e44c"]}],"sources":[{"id":"ctg-observation-nct00006077-2008-03-04-bfc2ad48e44c","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00006077 · retained source version 2008-03-04:bfc2ad48e44cf6ce3c25fcc4df1d42ff15839d86dd61ad54dee6c51da39367a1","url":"https://clinicaltrials.gov/study/NCT00006077"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"a2d11ec7c55e8125e7d4af70c2adf7d486c424001a175cb581b01b9633b2819a","tierARecordSha256":"6b6156782341a2cc4ddd864947cd7842ec7294f33831d022849a96de84dee2a5"},"integrity":{"algorithm":"sha256","contentSha256":"794389637636c21372726443c3e639d6579350e93c34dfe28c6de7711e823897"}},"clinicaltrials-gov-nct00394667-tesofensine-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00394667-tesofensine:v1","objectPathId":"clinicaltrials-gov-nct00394667-tesofensine-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00394667-tesofensine/","json":"https://peptidescanner.com/evidence/v1/peptides/tesofensine.json#clinicaltrials-gov-nct00394667-tesofensine-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/tesofensine.md#clinicaltrials-gov-nct00394667-tesofensine-v1"},"story":{"slug":"clinicaltrials-gov-nct00394667-tesofensine","version":1,"domain":"Clinical trials","dateInSource":"2013-04-22","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["tesofensine"],"peptides":[{"slug":"tesofensine","url":"https://peptidescanner.com/peptides/tesofensine/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00394667","sourceIds":["ctg-observation-nct00394667-2013-04-22-23740f6bc971"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00394667 at 2026-11-16T17:29:46.323Z. Its registry update date was 2013-04-22, and PeptideScanner's reviewed identity mapping was tesofensine.","sourceIds":["ctg-observation-nct00394667-2013-04-22-23740f6bc971"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00394667 at 2026-11-16T17:29:46.323Z. Its registry update date was 2013-04-22, and PeptideScanner's reviewed identity mapping was tesofensine.","sourceIds":["ctg-observation-nct00394667-2013-04-22-23740f6bc971"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00394667-2013-04-22-23740f6bc971"]}],"sources":[{"id":"ctg-observation-nct00394667-2013-04-22-23740f6bc971","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00394667 · retained source version 2013-04-22:23740f6bc971aaad5176bba9f9531c0693806f0153ab9267688789ec4ffd3ced","url":"https://clinicaltrials.gov/study/NCT00394667"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"9ee4710743b08957d8a30cf01a75cc66375580c31a0a87625d5a6031ab1dde02","tierARecordSha256":"7e084b128402faa28a0126b9a49b49683ac468784611dd95f744fc4bfdb270d7"},"integrity":{"algorithm":"sha256","contentSha256":"58ca312befe9adcc085412789d4d7cb34ac42d86ad3203415164b35d072bab33"}},"clinicaltrials-gov-nct00428415-tesofensine-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00428415-tesofensine:v1","objectPathId":"clinicaltrials-gov-nct00428415-tesofensine-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00428415-tesofensine/","json":"https://peptidescanner.com/evidence/v1/peptides/tesofensine.json#clinicaltrials-gov-nct00428415-tesofensine-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/tesofensine.md#clinicaltrials-gov-nct00428415-tesofensine-v1"},"story":{"slug":"clinicaltrials-gov-nct00428415-tesofensine","version":1,"domain":"Clinical trials","dateInSource":"2008-03-05","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["tesofensine"],"peptides":[{"slug":"tesofensine","url":"https://peptidescanner.com/peptides/tesofensine/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00428415","sourceIds":["ctg-observation-nct00428415-2008-03-05-4e496e834271"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00428415 at 2026-11-16T17:29:46.323Z. Its registry update date was 2008-03-05, and PeptideScanner's reviewed identity mapping was tesofensine.","sourceIds":["ctg-observation-nct00428415-2008-03-05-4e496e834271"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00428415 at 2026-11-16T17:29:46.323Z. Its registry update date was 2008-03-05, and PeptideScanner's reviewed identity mapping was tesofensine.","sourceIds":["ctg-observation-nct00428415-2008-03-05-4e496e834271"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00428415-2008-03-05-4e496e834271"]}],"sources":[{"id":"ctg-observation-nct00428415-2008-03-05-4e496e834271","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00428415 · retained source version 2008-03-05:4e496e834271649025e17fdfbb047db9af1d075bddbba6228167ae1d7b130492","url":"https://clinicaltrials.gov/study/NCT00428415"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"6789fd8d1d756bbe017c96e0bc6e88545a2025a4dd2baa3267c25181797035ac","tierARecordSha256":"8a8b40135ab45f82fd488e508dcfd3227490b5c2e160458cf00116f1985d60a7"},"integrity":{"algorithm":"sha256","contentSha256":"a9251b8dcb9b40623a58b6a06306628be04976f2471ebe93d4283daa5095a22e"}},"clinicaltrials-gov-nct00481104-tesofensine-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00481104-tesofensine:v1","objectPathId":"clinicaltrials-gov-nct00481104-tesofensine-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00481104-tesofensine/","json":"https://peptidescanner.com/evidence/v1/peptides/tesofensine.json#clinicaltrials-gov-nct00481104-tesofensine-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/tesofensine.md#clinicaltrials-gov-nct00481104-tesofensine-v1"},"story":{"slug":"clinicaltrials-gov-nct00481104-tesofensine","version":1,"domain":"Clinical trials","dateInSource":"2011-07-04","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["tesofensine"],"peptides":[{"slug":"tesofensine","url":"https://peptidescanner.com/peptides/tesofensine/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00481104","sourceIds":["ctg-observation-nct00481104-2011-07-04-d9da54defab7"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00481104 at 2026-11-16T17:29:46.323Z. Its registry update date was 2011-07-04, and PeptideScanner's reviewed identity mapping was tesofensine.","sourceIds":["ctg-observation-nct00481104-2011-07-04-d9da54defab7"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00481104 at 2026-11-16T17:29:46.323Z. Its registry update date was 2011-07-04, and PeptideScanner's reviewed identity mapping was tesofensine.","sourceIds":["ctg-observation-nct00481104-2011-07-04-d9da54defab7"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00481104-2011-07-04-d9da54defab7"]}],"sources":[{"id":"ctg-observation-nct00481104-2011-07-04-d9da54defab7","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00481104 · retained source version 2011-07-04:d9da54defab771f670ee27e2708e6211d99fe4540aad27f6d3f66b4d89148425","url":"https://clinicaltrials.gov/study/NCT00481104"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"9c4130767426621cc55c981524b658474115ce81b9d4056a78182608242ed2dd","tierARecordSha256":"86ae60647bb4ca2547239d4876e2464aea1211436692e8dc8347fea21f774f34"},"integrity":{"algorithm":"sha256","contentSha256":"83c6bae12d97b5bc060ad6f46ad7af7560e6c871337576c6127e150b31afa234"}},"clinicaltrials-gov-nct02737891-tesofensine-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct02737891-tesofensine:v1","objectPathId":"clinicaltrials-gov-nct02737891-tesofensine-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02737891-tesofensine/","json":"https://peptidescanner.com/evidence/v1/peptides/tesofensine.json#clinicaltrials-gov-nct02737891-tesofensine-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/tesofensine.md#clinicaltrials-gov-nct02737891-tesofensine-v1"},"story":{"slug":"clinicaltrials-gov-nct02737891-tesofensine","version":1,"domain":"Clinical trials","dateInSource":"2020-05-14","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["tesofensine"],"peptides":[{"slug":"tesofensine","url":"https://peptidescanner.com/peptides/tesofensine/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT02737891","sourceIds":["ctg-observation-nct02737891-2020-05-14-845ff8c8d2a7"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT02737891 at 2026-11-16T17:29:46.323Z. Its registry update date was 2020-05-14, and PeptideScanner's reviewed identity mapping was tesofensine.","sourceIds":["ctg-observation-nct02737891-2020-05-14-845ff8c8d2a7"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT02737891 at 2026-11-16T17:29:46.323Z. Its registry update date was 2020-05-14, and PeptideScanner's reviewed identity mapping was tesofensine.","sourceIds":["ctg-observation-nct02737891-2020-05-14-845ff8c8d2a7"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct02737891-2020-05-14-845ff8c8d2a7"]}],"sources":[{"id":"ctg-observation-nct02737891-2020-05-14-845ff8c8d2a7","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT02737891 · retained source version 2020-05-14:845ff8c8d2a70bec06db5592680ccbc4e9e9b8e982df2b5e72249edde4008671","url":"https://clinicaltrials.gov/study/NCT02737891"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"e5a2f913d6845824fd4721e92453b53be3bb2bd713de281c71615d39d35a95d9","tierARecordSha256":"d1a5c07266fd1f632fc88615d5ede024566ff1c85a2316bd39d7229a260f4b88"},"integrity":{"algorithm":"sha256","contentSha256":"22184bd7dacaf389728ab20519d79b1963e5633bbec7441dfd7696f5654323ac"}},"clinicaltrials-gov-nct03149445-tesofensine-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct03149445-tesofensine:v1","objectPathId":"clinicaltrials-gov-nct03149445-tesofensine-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03149445-tesofensine/","json":"https://peptidescanner.com/evidence/v1/peptides/tesofensine.json#clinicaltrials-gov-nct03149445-tesofensine-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/tesofensine.md#clinicaltrials-gov-nct03149445-tesofensine-v1"},"story":{"slug":"clinicaltrials-gov-nct03149445-tesofensine","version":1,"domain":"Clinical trials","dateInSource":"2024-02-26","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["tesofensine"],"peptides":[{"slug":"tesofensine","url":"https://peptidescanner.com/peptides/tesofensine/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT03149445","sourceIds":["ctg-observation-nct03149445-2024-02-26-00979aa158e1"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT03149445 at 2026-11-16T17:29:46.323Z. Its registry update date was 2024-02-26, and PeptideScanner's reviewed identity mapping was tesofensine.","sourceIds":["ctg-observation-nct03149445-2024-02-26-00979aa158e1"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT03149445 at 2026-11-16T17:29:46.323Z. Its registry update date was 2024-02-26, and PeptideScanner's reviewed identity mapping was tesofensine.","sourceIds":["ctg-observation-nct03149445-2024-02-26-00979aa158e1"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct03149445-2024-02-26-00979aa158e1"]}],"sources":[{"id":"ctg-observation-nct03149445-2024-02-26-00979aa158e1","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT03149445 · retained source version 2024-02-26:00979aa158e14135fd25e2de9993251f0216ccd72a5b19fff1cf475e407a3a20","url":"https://clinicaltrials.gov/study/NCT03149445"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"ad5238d03f108c350283ebee6a1776fe232f4e8110314a7e689f2226b5eeaef4","tierARecordSha256":"afde66158874f894c469c791431847624351dd23c67832c3b85358a6c0c40c1b"},"integrity":{"algorithm":"sha256","contentSha256":"88de05a0b3f17803222ed0924b876f4af0fb36da2b11c6675fb2916e98beed1a"}},"clinicaltrials-gov-nct03286829-tesofensine-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct03286829-tesofensine:v1","objectPathId":"clinicaltrials-gov-nct03286829-tesofensine-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03286829-tesofensine/","json":"https://peptidescanner.com/evidence/v1/peptides/tesofensine.json#clinicaltrials-gov-nct03286829-tesofensine-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/tesofensine.md#clinicaltrials-gov-nct03286829-tesofensine-v1"},"story":{"slug":"clinicaltrials-gov-nct03286829-tesofensine","version":1,"domain":"Clinical trials","dateInSource":"2020-05-14","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["tesofensine"],"peptides":[{"slug":"tesofensine","url":"https://peptidescanner.com/peptides/tesofensine/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT03286829","sourceIds":["ctg-observation-nct03286829-2020-05-14-e952543454a0"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT03286829 at 2026-11-16T17:29:46.323Z. Its registry update date was 2020-05-14, and PeptideScanner's reviewed identity mapping was tesofensine.","sourceIds":["ctg-observation-nct03286829-2020-05-14-e952543454a0"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT03286829 at 2026-11-16T17:29:46.323Z. Its registry update date was 2020-05-14, and PeptideScanner's reviewed identity mapping was tesofensine.","sourceIds":["ctg-observation-nct03286829-2020-05-14-e952543454a0"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct03286829-2020-05-14-e952543454a0"]}],"sources":[{"id":"ctg-observation-nct03286829-2020-05-14-e952543454a0","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT03286829 · retained source version 2020-05-14:e952543454a0416a5eba6cb8b05792880a499901a40b68e91c0cc08e4c7a7ab2","url":"https://clinicaltrials.gov/study/NCT03286829"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"17976ba5979ed8314412832efa376608c6b4f9de5d63aac515859e7a702cd54b","tierARecordSha256":"76cb0f8c6f5ae4ffa1b425a1d6668227fb76d1d8fa0097d36fdc61022732d5cb"},"integrity":{"algorithm":"sha256","contentSha256":"89221ca84d8024df2af082847aa565cf5359065f03cbdf9361fb68e23ef44896"}},"pubmed-pmid-17324246-tesofensine-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-17324246-tesofensine:v1","objectPathId":"pubmed-pmid-17324246-tesofensine-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-17324246-tesofensine/","json":"https://peptidescanner.com/evidence/v1/peptides/tesofensine.json#pubmed-pmid-17324246-tesofensine-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/tesofensine.md#pubmed-pmid-17324246-tesofensine-v1"},"story":{"slug":"pubmed-pmid-17324246-tesofensine","version":1,"domain":"Literature metadata","dateInSource":"2018-11-13","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["tesofensine"],"peptides":[{"slug":"tesofensine","url":"https://peptidescanner.com/peptides/tesofensine/"}]},"claims":[{"id":"headline","text":"Population pharmacokinetic modelling of NS2330 (tesofensine) and its major metabolite in patients with Alzheimer's disease.","sourceIds":["pubmed-observation-pmid-17324246-2018-11-13-d2a8f008a394"]},{"id":"summary","text":"PubMed lists PMID 17324246 in British journal of clinical pharmacology as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2007-02-23 (day precision). PeptideScanner associated the retained record with the identity slug tesofensine. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-17324246-2018-11-13-d2a8f008a394"]},{"id":"paragraph-1","text":"PubMed lists PMID 17324246 in British journal of clinical pharmacology as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2007-02-23 (day precision). PeptideScanner associated the retained record with the identity slug tesofensine. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-17324246-2018-11-13-d2a8f008a394"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-17324246-2018-11-13-d2a8f008a394"]}],"sources":[{"id":"pubmed-observation-pmid-17324246-2018-11-13-d2a8f008a394","name":"PubMed","sourceClass":"A","title":"Population pharmacokinetic modelling of NS2330 (tesofensine) and its major metabolite in patients with Alzheimer's disease. · retained source version 1:2018-11-13:current:d2a8f008a394d0082b9a23b921fbfeedbf6b1ca7a2ae58d5b04ac9401ad2a830","url":"https://pubmed.ncbi.nlm.nih.gov/17324246/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"1be9df1a57550b715a82d31dee2388a504cd043c1f4e0ba0026d8f3b4bbd6c99","tierARecordSha256":"a4bb4333e98e2cbfc38c24a6eef190893c2534dc637efd206959714eed86ce77"},"integrity":{"algorithm":"sha256","contentSha256":"19c0b468bc5f735c8444efd524ca16a81c26c4b27d9bedc23ff3e0c6bedee269"}},"pubmed-pmid-17982477-tesofensine-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-17982477-tesofensine:v1","objectPathId":"pubmed-pmid-17982477-tesofensine-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-17982477-tesofensine/","json":"https://peptidescanner.com/evidence/v1/peptides/tesofensine.json#pubmed-pmid-17982477-tesofensine-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/tesofensine.md#pubmed-pmid-17982477-tesofensine-v1"},"story":{"slug":"pubmed-pmid-17982477-tesofensine","version":1,"domain":"Literature metadata","dateInSource":"2021-10-20","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["tesofensine"],"peptides":[{"slug":"tesofensine","url":"https://peptidescanner.com/peptides/tesofensine/"}]},"claims":[{"id":"headline","text":"Contribution of the active metabolite M1 to the pharmacological activity of tesofensine in vivo: a pharmacokinetic-pharmacodynamic modelling approach.","sourceIds":["pubmed-observation-pmid-17982477-2021-10-20-7dbcf0e2e522"]},{"id":"summary","text":"PubMed lists PMID 17982477 in British journal of pharmacology as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2007-11-05 (day precision). PeptideScanner associated the retained record with the identity slug tesofensine. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-17982477-2021-10-20-7dbcf0e2e522"]},{"id":"paragraph-1","text":"PubMed lists PMID 17982477 in British journal of pharmacology as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2007-11-05 (day precision). PeptideScanner associated the retained record with the identity slug tesofensine. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-17982477-2021-10-20-7dbcf0e2e522"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-17982477-2021-10-20-7dbcf0e2e522"]}],"sources":[{"id":"pubmed-observation-pmid-17982477-2021-10-20-7dbcf0e2e522","name":"PubMed","sourceClass":"A","title":"Contribution of the active metabolite M1 to the pharmacological activity of tesofensine in vivo: a pharmacokinetic-pharmacodynamic modelling approach. · retained source version 1:2021-10-20:current:7dbcf0e2e522bc2c0d15a2f63fecbba504d75e38c3c73320992b75eddf2114a3","url":"https://pubmed.ncbi.nlm.nih.gov/17982477/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"c3f15d96b03b5f251085e0ba79859a7e70c13bbec9754baf88aa874ce22ea62e","tierARecordSha256":"4bf946e8b3df1d619541f53917c538a928e9001bd0f4d058b2927b6e034a8283"},"integrity":{"algorithm":"sha256","contentSha256":"de7f2cd3c3ba340b34b99610643ca9a1ddec5278c605dc167ca8c09a74863741"}},"pubmed-pmid-19705923-tesofensine-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-19705923-tesofensine:v1","objectPathId":"pubmed-pmid-19705923-tesofensine-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-19705923-tesofensine/","json":"https://peptidescanner.com/evidence/v1/peptides/tesofensine.json#pubmed-pmid-19705923-tesofensine-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/tesofensine.md#pubmed-pmid-19705923-tesofensine-v1"},"story":{"slug":"pubmed-pmid-19705923-tesofensine","version":1,"domain":"Literature metadata","dateInSource":"2021-10-20","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["tesofensine"],"peptides":[{"slug":"tesofensine","url":"https://peptidescanner.com/peptides/tesofensine/"}]},"claims":[{"id":"headline","text":"A quantitative enterohepatic circulation model: development and evaluation with tesofensine and meloxicam.","sourceIds":["pubmed-observation-pmid-19705923-2021-10-20-6ca15a400765"]},{"id":"summary","text":"PubMed lists PMID 19705923 in Clinical pharmacokinetics as Comparative Study, Controlled Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2009 (year precision). PeptideScanner associated the retained record with the identity slug tesofensine. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-19705923-2021-10-20-6ca15a400765"]},{"id":"paragraph-1","text":"PubMed lists PMID 19705923 in Clinical pharmacokinetics as Comparative Study, Controlled Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2009 (year precision). PeptideScanner associated the retained record with the identity slug tesofensine. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-19705923-2021-10-20-6ca15a400765"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-19705923-2021-10-20-6ca15a400765"]}],"sources":[{"id":"pubmed-observation-pmid-19705923-2021-10-20-6ca15a400765","name":"PubMed","sourceClass":"A","title":"A quantitative enterohepatic circulation model: development and evaluation with tesofensine and meloxicam. · retained source version 1:2021-10-20:current:6ca15a4007650983c8047cd3e6ad8747d419aabb38f444f738d9d60bce71acc4","url":"https://pubmed.ncbi.nlm.nih.gov/19705923/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"732815b958d29418bc214339567c8d6b7ba4c29cee2a0abd9d0df9ea86d9bb86","tierARecordSha256":"c23156bdfc756d913c25155867cd34da663abe1d451661a345a4bcbc6779d73f"},"integrity":{"algorithm":"sha256","contentSha256":"828d98820136046bda862d76f0e9bdeb5ce29e814c919d4a3d6e472f2a14968a"}},"pubmed-pmid-42320973-tesofensine-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-42320973-tesofensine:v1","objectPathId":"pubmed-pmid-42320973-tesofensine-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-42320973-tesofensine/","json":"https://peptidescanner.com/evidence/v1/peptides/tesofensine.json#pubmed-pmid-42320973-tesofensine-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/tesofensine.md#pubmed-pmid-42320973-tesofensine-v1"},"story":{"slug":"pubmed-pmid-42320973-tesofensine","version":1,"domain":"Literature metadata","dateInSource":"2026-09-03","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["tesofensine"],"peptides":[{"slug":"tesofensine","url":"https://peptidescanner.com/peptides/tesofensine/"}]},"claims":[{"id":"headline","text":"Investigations Into the Metabolism and Elimination of Tesofensine in Human Urine.","sourceIds":["pubmed-observation-pmid-42320973-2026-09-03-9ce603371198"]},{"id":"summary","text":"PubMed lists PMID 42320973 in Drug testing and analysis as Journal Article, with publication-date metadata of 2026-06-19 (day precision). PeptideScanner associated the retained record with the identity slug tesofensine. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-42320973-2026-09-03-9ce603371198"]},{"id":"paragraph-1","text":"PubMed lists PMID 42320973 in Drug testing and analysis as Journal Article, with publication-date metadata of 2026-06-19 (day precision). PeptideScanner associated the retained record with the identity slug tesofensine. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-42320973-2026-09-03-9ce603371198"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-42320973-2026-09-03-9ce603371198"]}],"sources":[{"id":"pubmed-observation-pmid-42320973-2026-09-03-9ce603371198","name":"PubMed","sourceClass":"A","title":"Investigations Into the Metabolism and Elimination of Tesofensine in Human Urine. · retained source version 1:2026-09-03:current:9ce603371198019b7cdb9d063b030038b74341a1eb2d5121e8ce44ba2a3ffc47","url":"https://pubmed.ncbi.nlm.nih.gov/42320973/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"92469dac7481a4cab03bf99e8a0c19e925d343e7dd35af0bb5b11d00152b4973","tierARecordSha256":"d67a67e47ac9e774bd9252224a7ec46cb1a41f8db3258e3574d831db7f10204a"},"integrity":{"algorithm":"sha256","contentSha256":"bbf51bcd7e206c7488865357b1ce38d59da9a7f77df170e0dcb50e7bd6c499f7"}}}}
